Publikationen, an denen er mitarbeitet José Antonio Cartón Sánchez (112)

2021

  1. The TNF-α (–238 G/A) polymorphism could protect against development of severe sepsis

    Innate Immunity, Vol. 27, Núm. 5, pp. 409-420

2020

  1. Ethambutol-resistant Mycobacterium kansasii cervical lymphadenitis in an immunocompetent adult patient: A case report and literature review

    Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol. 18

  2. How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain

    HIV Medicine, Vol. 21, Núm. 2, pp. 128-134

2019

  1. The N125S polymorphism in the cathepsin G gene (rs45567233) is associated with susceptibility to osteomyelitis in a Spanish population

    PLoS ONE, Vol. 14, Núm. 10

2018

  1. A fatal case of Babesia divergens infection in Northwestern Spain

    Ticks and Tick-borne Diseases, Vol. 9, Núm. 3, pp. 730-734

  2. Bacterial osteomyelitis: Microbiological, clinical, therapeutic, and evolutive characteristics of 344 episodes

    Revista Espanola de Quimioterapia, Vol. 31, Núm. 3, pp. 217-225

  3. Factors predictive of relapse in adult bacterial osteomyelitis of long bones. 11 Medical and Health Sciences 1103 Clinical Sciences

    BMC Infectious Diseases, Vol. 18, Núm. 1

  4. Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients

    Medicine (United States), Vol. 97, Núm. 38

  5. Low-level viremia is associated with clinical progression in HIV-infected patients receiving antiretroviral treatment

    Journal of Acquired Immune Deficiency Syndromes, Vol. 78, Núm. 3, pp. 329-337

2017

  1. Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach

    PLoS ONE, Vol. 12, Núm. 9

2016

  1. Factors associated with long-term CD4 cell recovery in HIV-infected patients on successful antiretroviral therapy

    HIV Medicine, Vol. 17, Núm. 7, pp. 532-541

  2. Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013

    Journal of Infection, Vol. 72, Núm. 5, pp. 587-596

  3. MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression

    PLoS ONE, Vol. 11, Núm. 5

2015

  1. CD4+CD28null T lymphocytes resemble CD8+CD28null T lymphocytes in their responses to IL-15 and IL-21 in HIV-infected patients

    Journal of Leukocyte Biology, Vol. 98, Núm. 3, pp. 373-384

  2. Differential body composition effects of protease inhibitors recommended for initial treatment of HIV infection: A randomized clinical trial

    Clinical Infectious Diseases, Vol. 60, Núm. 5, pp. 811-820

  3. Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

    The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 775-784

  4. Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)

    Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 105.e1-105.e5

2014

  1. Endothelial (NOS3 E298D) and inducible (NOS2 exon 22) nitric oxide synthase polymorphisms, as well as plasma NOx, influence sepsis development

    Nitric Oxide - Biology and Chemistry, Vol. 42, pp. 79-86

  2. Immune reconstitution inflammatory syndrome-unmasking endophthalmic, lymphadenopathic, and neuromeningeal cryptococcosis in an HIV-infected patient starting highly active antiretroviral therapy

    AIDS Research and Human Retroviruses

  3. Incidence of Hepatitis C Virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: Increasing rates of HCV diagnosis but not of HCV seroconversions

    PLoS ONE, Vol. 9, Núm. 12